8 Patents
- US1256547620262,5-disubstituted 3-methyl Pyrazines and 2,5,6-trisubstituted 3-methyl Pyrazines as Allosteric SHP2 Inhibitors
Revolution Medicines, Inc.
0 cites - US125344532026Inhibitors of Glycogen Synthase 1 (GYS1) and Methods of Use Thereof
Maze Therapeutics, Inc.
0 cites - US123656882025Substituted Pyrazolopyrazines, Imidazopyrazines and [1,2,4]triazolopyrazines as Allosteric SHP2 Inhibitors
Revolution Medicines, Inc.
0 cites - US118143672023Inhibitors of Glycogen Synthase 1 (GYS1) and Methods of Use Thereof
MAZE THERAPEUTICS, Inc.
0 cites - US117390932023Substituted Pyrazolopyrazines, Imidazopyrazines and [1,2,4]triazolopyrazines as Allosteric SHP2 Inhibitors
REVOLUTION MEDICINES, Inc.
0 cites - US117024112023Pyridine, Pyrazine, and Triazine Compounds as Allosteric SHP2 Inhibitors
REVOLUTION MEDICINES, Inc.
0 cites - 0 cites
- US1166140120232,5-disubstituted 3-methyl Pyrazines and 2,5,6-trisubstituted 3-methyl Pyrazines as Allosteric SHP2 Inhibitors
REVOLUTION MEDICINES, Inc.
0 cites